Blood · 2006 · 29 citations · 47 references
Life SciencesImmunologyPathologyCellular ImmunologyImmunopathologyTransplant ImmunologyAlloantigen RecognitionAllograft RejectionInnate Immunity In TransplantationT Cell BiologyTransplant RejectionAllograft Rejection MechanismsAlloreactive T Cell ResponsesCytokine-mediated AlloresponseImmunologic Response To AllograftNaive T CellsT Cell - Mediated RejectionT Cell-mediated Graft RejectionT-cell Mediated Rejection
Allograft transplantation requires chronic immunosuppression, but there is no effective strategy to evaluate the long-term maintenance of immunosuppression other than assessment of graft function. The ability to monitor naive alloreactive T cells would provide an alternative guide for drug therapy at early, preclinical stages of graft rejection and for evaluating tolerance-inducing protocols. To detect and quantify naive alloreactive T cells directly ex vivo, we used the unique ability of naive T cells to rapidly produce TNF-alpha but not IFN-gamma. Naive alloreactive T cells were identified by the production of TNF-alpha after a 5-hour in vitro stimulation with alloantigen and were distinguished from effector/memory alloreactive T cells by the inability to produce IFN-gamma. Moreover, naive alloreactive T cells were not detected in mice tolerized against specific alloantigens. The frequency of TNF-alpha-producing cells was predictive for rejection in an in vivo cytotoxicity assay and correlated with skin allograft rejection. Naive alloreactive T cells were also detected in humans, suggesting clinical relevance. We conclude that rapid production of TNF-alpha can be used to quantify naive alloreactive T cells, that it is abrogated after the induction of tolerance, and that it is a potential tool to predict allograft rejection.
47
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Christian P. Larsen, Eric T. Elwood, Diane Z. Alexander et al. · Nature · 1996 · 1.5K citations